Showing results (1401-1410 of 1,427) with videos related to
Sort By:
Pageof 143
Public Health Genomics|January 19, 2025
Investigating the Impact of Screen-Sharing Visual Aids during Genomic Results Disclosure via Telehealth in Diverse Families in the TeleKidSeq Pilot StudyJacqueline A Odgis, Nicole R Kelly, Monisha Sebastin, et al.Cancer Research|June 7, 2020
The EMT Transcription Factor ZEB2 Promotes Proliferation of Primary and Metastatic Melanoma While Suppressing an Invasive, Mesenchymal-Like PhenotypeNiels Vandamme, Geertrui Denecker, Kenneth Bruneel, et al.Clinical Genetics|June 19, 2023
Identification of copy number variants with genome sequencing: Clinical experiences from the NYCKidSeq programKatherine E Bonini, Amanda Thomas-Wilson, Priya N Marathe, et al.Melanoma Research|March 10, 2015
High-throughput oncogene mutation profiling shows demographic differences in BRAF mutation rates among melanoma patientsKarin van den Hurk, Balazs Balint, Sinead Toomey, et al.HGG Advances|June 26, 2024
Evaluating parental personal utility of pediatric genetic and genomic testing in a diverse, multilingual populationPriya N Marathe, Sabrina A Suckiel, Katherine E Bonini, et al.Nature Medicine|June 2, 2015
Epigenetic activation of a cryptic TBC1D16 transcript enhances melanoma progression by targeting EGFRMiguel Vizoso, Humberto J Ferreira, Paula Lopez-Serra, et al.Genetics in Medicine : Official Journal of the American College of Medical Genetics|February 3, 2021
GUÍA: a digital platform to facilitate result disclosure in genetic counselingSabrina A Suckiel, Jaqueline A Odgis, Katie M Gallagher, et al.Nature Communications|October 7, 2018
Copy number load predicts outcome of metastatic colorectal cancer patients receiving bevacizumab combination therapyDominiek Smeets, Ian S Miller, Darran P O'Connor, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 25, 2018
Loss of Chromosome 18q11.2-q12.1 Is Predictive for Survival in Patients With Metastatic Colorectal Cancer Treated With BevacizumabErik van Dijk, Hedde D Biesma, Martijn Cordes, et al.Journal of the American Chemical Society|March 19, 2021
Design of BET Inhibitor Bottlebrush Prodrugs with Superior Efficacy and Devoid of Systemic ToxicitiesFarrukh Vohidov, Jannik N Andersen, Kyriakos D Economides, et al.Pageof 143